Clinical studies recruiting near Chengdu

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NA · West China Hospital Sichuan University · Second Affiliated Hospital, Zhejiang University, School of M · NCT04078230 Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Affiliated Hospital of Chengdu University of Traditional Chi · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 Evaluate the Effect of Remote Exercise Intervention on Blood Glucose Control and Physical Fitness in T2DM Patients
NA · Sichuan Provinvial People's HSichuan Academy of Medical Scie · Sichuan Academy of Medical Sciences · NCT07676773 A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · Sichuan Provincial People's Hospital · R1 Therapeutics · NCT06712654 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · West China Hospital, Sichuan University · Eli Lilly and Company · NCT07218380 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-56007, Chengdu City, Sichuan Province · Colorado Prevention Center · NCT06024746 Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · West China Hospital, Sichuan University · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · West China Second University Hospital, Sichuan University · Daiichi Sankyo · NCT07022483 Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors
Phase 1 · West China Hospital of Sichuan University · West China Hospital · NCT07583654 Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
Phase 2 · West China hospital · West China Hospital · NCT06482086 AI App for Management of Atopic Dermatitis
NA · West China Hospital, Sichuan University · West China Hospital · NCT06362629 A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumo
Phase N/A · Research Site · AstraZeneca · NCT07404202 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · West China Hospital, Sichuan University-Head and Neck Oncolo · Merck Sharp & Dohme LLC · NCT06136559 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Sichuan Cancer hospital · Bristol-Myers Squibb · NCT07106762 A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · Sichuan Provincial People's Hospital · Huabo Biopharm Co., Ltd. · NCT06592274 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Sichuan Cancer hospital · Pfizer · NCT06758401 A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Local Institution - 0179 · Bristol-Myers Squibb · NCT06929273 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · Sichuan Provincial People's Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 Assessment System for Sarcopenia Based on Ultrasonographic Data
Phase N/A · Xinyi Tang · West China Hospital · NCT06199856 Structured Active Follow-up in Postoperative Management of Thyroid
NA · West China hospital of Sichuan University · Yu Feng · NCT07589660 Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients
Phase 2 · West China Hospital of Sichuan University · West China Hospital · NCT06437158 Predicting Tumor Origin Based on Deep Learning of Lymph Node Puncture Cytology
Phase N/A · West China Hospital of Sichuan University · West China Hospital · NCT06810349 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · West China Hospital, Sichuan University · Boehringer Ingelheim · NCT07355296 Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
NA · West China Hospital Sichuan University · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06146946 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · West China Hospital of Sichuan University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 Allogeneic UCB-derived CAR-T for SLE
EARLY_Phase 1 · The General Hospital of Western Theater Command · Chengdu Ucello Biotechnology Co., Ltd. · NCT07274059 Clinical Trial of TQB3002 in Patients With Advanced Cancers
Phase 1 · Sichuan Cancer Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06662760 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · West China Hospital of Sichuan University · Takeda · NCT06671496 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · Investigational Site Number : 1560012 · Sanofi · NCT07190196 Bactiseal Catheter Safety Registry Study
Phase N/A · West China Hospital of Sichuan University · Integra LifeSciences Corporation · NCT06276543

Look up another city

Look up another condition